A Multi-Center, Open-Label, Two-Part Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics of RO7079901

Trial Profile

A Multi-Center, Open-Label, Two-Part Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics of RO7079901

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs RO 7079901 (Primary)
  • Indications Unspecified
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 09 Aug 2017 Status changed from recruiting to completed.
    • 19 Apr 2017 Planned End Date changed from 30 Jun 2017 to 25 Jul 2017.
    • 19 Apr 2017 Planned primary completion date changed from 30 Jun 2017 to 25 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top